Mutation H63D in the HFE gene confers risk for the development of type 2 diabetes mellitus but not for chronic complications
Authors:
- Máikel L. ColliMCMáikel L. Colli
- Jorge L. GrossJGJorge L. Gross
- Luis H. CananiLCLuis H. Canani
- 28 February 2011
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 25 (1) , 25-30
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 DiabetesDiabetes Care, 2008
- HFE mutations and risk of coronary heart disease in middle‐aged womenEuropean Journal of Clinical Investigation, 2006
- Hereditary HemochromatosisAnnual Review of Nutrition, 2006
- The G1888A variant in the mitochondrial 16S rRNA gene may be associated with Type 2 diabetes in Caucasian–Brazilian patients from southern BrazilDiabetic Medicine, 2005
- A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetesJournal of Human Genetics, 2003
- Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USAThe Lancet, 2002
- HFE Gene and Hereditary Hemochromatosis: A HuGE ReviewAmerican Journal of Epidemiology, 2001
- Use and misuse of population attributable fractions.American Journal of Public Health, 1998
- A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosisNature Genetics, 1996
- Factors determining glucose tolerance in patients with thalassemia majorThe Journal of Clinical Endocrinology & Metabolism, 1993